Safety practices and opportunities for improvement in brachytherapy: A patient safety practices survey of the American Brachytherapy Society membership.

PURPOSE: Safe delivery of brachytherapy and establishing a safety culture are critical in high-quality brachytherapy. The American Brachytherapy Society (ABS) Quality and Safety Committee surveyed members regarding brachytherapy services offered, safety practices during treatment, quality assurance procedures, and needs to develop safety and training materials. METHODS AND MATERIALS: A 22-item survey was sent to ABS membership in early 2019 to physicians, physicists, therapists, nurses, and administrators. Participation was voluntary. Responses were summarized with descriptive statistics and relative frequency distributions. RESULTS: There were 103 unique responses. Approximately one in three was attending physicians and one in three attending physicists. Most were in practice >10 years. A total of 94% and 50% performed gynecologic and prostate brachytherapy, respectively. Ninety-one percent performed two-identification patient verification before treatment. Eighty-six percent performed a time-out. Ninety-five percent had an incident reporting or learning system, but only 71% regularly reviewed incidents. Half reviewed safety practices within the last year. Twenty percent reported they were somewhat or not satisfied with department safety culture, but 92% of respondents were interested in improving safety culture. Most reported time, communication, and staffing as barriers to improving safety. Most respondents desired safety-oriented webinars, self-assessment modules, learning modules, or checklists endorsed by the ABS to improve safety practice. CONCLUSIONS: Most but not all practices use standards and quality assurance procedures in line with society recommendations. There is a need to heighten safety culture at many departments and to shift resources (e.g., time or staffing) to improve safety practice. There is a desire for society guidance to improve brachytherapy safety practices. This is the first survey to assess safety practice patterns among a national sample of radiation oncologists with expertise in brachytherapy.

A preliminary study on a multiresolution-level inverse planning approach for Gamma Knife radiosurgery.

PURPOSE: With many plan variables to determine, manual forward planning for Gamma Knife (GK) radiosurgery is very challenging. Inverse planning eases GK planning by determining the variables via solving an optimization problem. However, due to the vast search space, most inverse planning algorithms, including the one provided in Leksell GammaPlan (LGP) treatment planning system, have to predetermine the isocenter locations using some geometric methods and then optimize the shot shapes and durations at these preselected isocenters. This sequential planning scheme does not necessarily lead to optimal isocenter locations and hence globally optimal plans. In this study, we proposed a multiresolution-level (MRL) inverse planning approach, attempting to approach this large-scale GK optimization problem via an iterative method. METHODS: In our MRL approach, several rounds of optimizations were performed with a progressively increased resolution used for isocenter candidates. At each round, an optimization problem was solved to optimize the beam-on time for each collimator and sector at each isocenter candidate. The isocenters that obtained nonzero beam-on times at the previous round and their neighbors on a finer resolution were used as new isocenter candidates for the next round of optimization. After plan optimization, shot sequencing was performed to group the optimized sectors to deliverable composite shots. RESULTS: We have tested our MRL approach on six GK cases previously treated in our institution. For the five cases that have a single target, with similar target coverage obtained, our MRL inverse planning approach achieved better plan quality compared to manual forward planning and LGP inverse planning, with higher selectivity (0.73 ± 0.07 vs 0.72 ± 0.08 and 0.62 ± 0.10), lower gradient index (2.71 ± 0.25 vs 2.78 ± 0.24 and 3.00 ± 0.29), lower brainstem D0.1cc dose (6.10 ± 4.46 Gy vs 8.87 ± 4.82 Gy and 9.17 ± 3.80 Gy), and shorter total beam-on time (62.1 ± 22.9 min vs 83.6 ± 28.2 min and 70.7 ± 16.7 min). For the case that have six targets, compared with manual planning and LGP inverse planning, our MRL approach achieved higher selectivity (0.68 vs 0.57 and 0.47) and lower gradient index (3.77 vs 4.51 and 5.11). The beam-on time of our plan was slightly longer than manual planning and LGP inverse planning (206.4 min vs 204.7 min and 199.3 min). We have also performed sector duration optimization at the isocenters determined by manual planning or the LGP inverse planning, and the resulting plan qualities were found to be inferior to our MRL approach for all the six cases. CONCLUSIONS: This preliminary study has demonstrated the efficacy and feasibility of our MRL inverse planning approach for GK radiosurgery.

Multiparametric MRI-guided dose boost to dominant intraprostatic lesions in CT-based High-dose-rate prostate brachytherapy.

OBJECTIVE: The purpose of this study is to investigate the dosimetric feasibility of delivering focal dose to multiparametric (mp) MRI-defined DILs in CT-based high-dose-rate (HDR) prostate brachytherapy with MR/CT registration and estimate its clinical benefit. METHODS: We retrospectively investigated a total of 17 patients with mp-MRI and CT images acquired pre-treatment and treated by HDR prostate brachytherapy. 21 dominant intraprostatic lesions (DILs) were contoured on mp-MRI and propagated to CT images using a deformable image registration method. A boost plan was created for each patient and optimized on the original needle pattern. In addition, separate plans were generated using a virtually implanted needle around the DIL to mimic mp-MRI guided needle placement. DIL dose coverage and organ-at-rick (OAR) sparing were compared with original plan results. Tumor control probability (TCP) was estimated to further evaluate the clinical impact on the boost plans. RESULTS: Overall, optimized boost plans significantly escalated dose to DILs while meeting OAR constraints. The addition of mp-MRI guided virtual needles facilitate increased coverage of DIL volumes, achieving a V150 > 90% in 85 % of DILs compared with 57 % of boost plan without an additional needle. Compared with original plan, TCP models estimated improvement in DIL control by 28 % for patients with external-beam treatment and by 8 % for monotherapy patients. CONCLUSION: With MR/CT registration, the proposed mp-MRI guided DIL boost in CT-based HDR brachytherapy is feasible without violating OAR constraints, and indicates significant clinical benefit in improving TCP of DIL. It may represent a strategy to personalize treatment delivery and improve tumor control. ADVANCES IN KNOWLEDGE: This study investigated the feasibility of mp-MRI guided DIL boost in HDR prostate brachytherapy with CT-based treatment planning, and estimated its clinical impact by TCP and NTCP estimation.